Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

@article{Maestu2003GemcitabineAL,
  title={Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.},
  author={Inma Maestu and Lorenzo G{\'o}mez-Aldarav{\'i} and Mar{\'i}a Dolores Torregrosa and Carlos Camps and Cristina Llorca and Carles Bosch and Joaqu{\'i}n G{\'o}mez and Vicente Giner and Amparo Oltra and Ana Albert},
  journal={Lung cancer},
  year={2003},
  volume={42 3},
  pages={345-54}
}
BACKGROUND Fifty percent of lung cancers arise in patients over 65 years old and 30% in those over 70. The aim of this study was to evaluate response, survival and tolerability of the combination carboplatin-gemcitabine in elderly patients with advanced non-small cell lung cancer (NSCLC). METHODS Between May 1998 and December 2000, 88 patients were included. Median age was 74 (range 65-83). Treatment consisted of gemcitabine 1250 mg/m(2) (1000 mg/m(2) in the first six patients) on days 1 and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…